Whitney Tilson Announces Another Big Short

Whitney Tilson Announces Another Big Short
Whitney Tilson

From Whitney Tilson via email: RE Opko Health Inc. (NYSE:OPK)

Also see ilson on K12 ‘My response to Dear Whitney – Are we having fun yet?’ and  Whitney Tilson On Why He Loves 3D Systems As a Short

Whitney Tilson

Run, don’t walk, to read this takedown of Opko Health Inc. (NYSE:OPK) (below and attached) – it’s one of the best I’ve ever read.

This mining and metals fund is having a strong year so far

Cubic Corporation Chris Hohn favorite hedge fundsThe Delbrook Resources Opportunities Master Fund was up 9.2% for May, bringing its year-to-date return to 33%. Q1 2021 hedge fund letters, conferences and more Dellbrook is an equity long/ short fund that focuses exclusively on the metals and mining sector. It invests mainly in public companies focused on precious, base, energy and industrial metals Read More


I saw Anthony Bozza of Lakewood Capital present this at the Robin Hood Investors Conference and it was so blindingly obvious that he’s right that, after doing my own work, I shorted it (first at a bit under $10, then more recently as the stock ran up over $11).


Bozza is one of the very best short sellers out there and this is the first time he’s ever written publicly.


Sent: Wednesday, December 11, 2013 8:38 AM
Subject: OPK Opko Health trading lower; Lakewood Capital reiterates short thesis ($11.50)
Importance: High


OPK Opko Health trading lower; Lakewood Capital reiterates short thesis ($11.50)

  • Recall on 21-Nov, shares of OPK traded sharply lower following Lakewood’s presentation of its short thesis at the Robin Hood Investors Conference
  • Today, Lakewood publicly released its analysis on OPK in response to a bullish article by TheStreetSweeper that had been released on 25-Nov in rebuttal to Lakewood’s presentation at the conference.
  • Lakewood believes shares of OPK are worth 75-100% less than where they are currently trading given the company’s history of failures, the low likelihood of meaningful commercial success in any of OPK’s products, the company’s financial performance, and unrealistic bullish analyst forecasts
  • Shares of OPK are currently trading (6.0%) at $10.81


Full document in pdf Opko Health report-Lakewood Capital-12-11-13

Opko Health Report-Lakewood Capital-12!11!13 by ValueWalk.com

No posts to display